End-of-day quote
Shanghai S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
38.55
CNY
|
-2.38%
|
|
-2.03%
|
-1.71%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,484
|
6,523
|
5,308
|
5,232
|
-
|
-
|
Enterprise Value (EV)
1 |
7,484
|
6,523
|
6,182
|
5,232
|
5,232
|
5,232
|
P/E ratio
|
41.6
x
|
33.5
x
|
23.3
x
|
20.1
x
|
15.5
x
|
13.8
x
|
Yield
|
0.67%
|
-
|
1.91%
|
2%
|
2.25%
|
2.89%
|
Capitalization / Revenue
|
13
x
|
9.39
x
|
6.64
x
|
5.28
x
|
4.1
x
|
3.85
x
|
EV / Revenue
|
13
x
|
9.39
x
|
6.64
x
|
5.28
x
|
4.1
x
|
3.85
x
|
EV / EBITDA
|
-
|
27.3
x
|
18.8
x
|
16
x
|
11.8
x
|
10.9
x
|
EV / FCF
|
-
|
29.5
x
|
110
x
|
13.3
x
|
28.1
x
|
16.5
x
|
FCF Yield
|
-
|
3.38%
|
0.91%
|
7.53%
|
3.56%
|
6.06%
|
Price to Book
|
8.23
x
|
6.17
x
|
4.16
x
|
3.57
x
|
3.01
x
|
2.6
x
|
Nbr of stocks (in thousands)
|
133,333
|
133,333
|
135,328
|
132,483
|
-
|
-
|
Reference price
2 |
56.13
|
48.92
|
39.22
|
39.49
|
39.49
|
39.49
|
Announcement Date
|
2/24/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
576.2
|
694.9
|
799.6
|
991.3
|
1,278
|
1,358
|
EBITDA
1 |
-
|
-
|
239.2
|
281.9
|
328
|
442.5
|
480
|
EBIT
1 |
-
|
181.8
|
227.9
|
264.2
|
310.5
|
402.5
|
452.5
|
Operating Margin
|
-
|
31.56%
|
32.79%
|
33.04%
|
31.32%
|
31.51%
|
33.33%
|
Earnings before Tax (EBT)
1 |
-
|
181.8
|
227.5
|
264.2
|
310.5
|
402
|
452.5
|
Net income
1 |
116.5
|
157
|
195.2
|
225.6
|
265
|
344.8
|
387
|
Net margin
|
-
|
27.25%
|
28.09%
|
28.22%
|
26.73%
|
26.99%
|
28.5%
|
EPS
2 |
-
|
1.350
|
1.460
|
1.680
|
1.960
|
2.548
|
2.860
|
Free Cash Flow
1 |
-
|
-
|
220.8
|
48.34
|
394
|
186
|
317
|
FCF margin
|
-
|
-
|
31.77%
|
6.05%
|
39.75%
|
14.56%
|
23.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
92.28%
|
17.15%
|
120.12%
|
42.03%
|
66.04%
|
FCF Conversion (Net income)
|
-
|
-
|
113.09%
|
21.42%
|
148.68%
|
53.95%
|
81.91%
|
Dividend per Share
2 |
-
|
0.3750
|
-
|
0.7500
|
0.7900
|
0.8900
|
1.140
|
Announcement Date
|
5/18/21
|
2/24/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
154.5
|
175.9
|
162.4
|
202
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
54.04
|
61.19
|
51.73
|
60.92
|
Operating Margin
|
34.97%
|
34.79%
|
31.85%
|
30.15%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/26/22
|
8/19/22
|
10/24/22
|
2/27/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
875
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
3.103
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
221
|
48.3
|
394
|
186
|
317
|
ROE (net income / shareholders' equity)
|
-
|
25.7%
|
19.9%
|
18.8%
|
18.1%
|
19.9%
|
19%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
11.1%
|
7.98%
|
7.5%
|
9.8%
|
9%
|
Assets
1 |
-
|
-
|
1,760
|
2,828
|
3,533
|
3,518
|
4,300
|
Book Value Per Share
2 |
-
|
6.820
|
7.930
|
9.430
|
11.10
|
13.10
|
15.20
|
Cash Flow per Share
2 |
-
|
-
|
2.220
|
1.180
|
2.380
|
2.530
|
2.710
|
Capex
1 |
-
|
-
|
75.6
|
111
|
95
|
67.8
|
67.5
|
Capex / Sales
|
-
|
-
|
10.88%
|
13.85%
|
9.58%
|
5.3%
|
4.97%
|
Announcement Date
|
5/18/21
|
2/24/22
|
2/27/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
39.49
CNY Average target price
49.75
CNY Spread / Average Target +25.98% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.69% | 723M | | +2.92% | 49.69B | | +19.98% | 42.41B | | +23.39% | 26.65B | | +12.04% | 19.62B | | +0.75% | 17.1B | | -24.51% | 15.43B | | +3.42% | 15.64B | | -9.92% | 15.3B | | -18.80% | 13.97B |
Other Specialty Chemicals
|